Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02526329
What this trial is testing

Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
Everett Meyer
Testing effectiveness (Phase 2)Study completedNCT00058305
What this trial is testing

Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+9 more
National Cancer Institute (NCI) 28
Large-scale testing (Phase 3)Study completedNCT00784537
What this trial is testing

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

Who this might be right for
Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 520
Testing effectiveness (Phase 2)Study completedNCT00750659
What this trial is testing

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation
Sheba Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00770757
What this trial is testing

CC-4047 (Pomalidomide) for Graft vs. Host Disease

Who this might be right for
Graft vs Host Disease
Washington University School of Medicine 13
Not applicableUnknownNCT05486273
What this trial is testing

Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells

Who this might be right for
Hematological Cancer
Institut Paoli-Calmettes 108
Large-scale testing (Phase 3)Looking for participantsNCT06083129
What this trial is testing

Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor

Who this might be right for
GVHD
Assistance Publique - Hôpitaux de Paris 324
Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Who this might be right for
Multiple Myeloma
Sanofi 23
Testing effectiveness (Phase 2)Looking for participantsNCT06657391
What this trial is testing

Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia

Who this might be right for
Transfusion Dependent Thalassemia
Rongrong Liu 396
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Testing effectiveness (Phase 2)Looking for participantsNCT06447090
What this trial is testing

VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT

Who this might be right for
Relapse Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Testing effectiveness (Phase 2)Study completedNCT03879876
What this trial is testing

Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients

Who this might be right for
Pediatric PatientsAny Type of Severe Combined Immunodeficiency (SCID)Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Assistance Publique - Hôpitaux de Paris 4
Post-approval studies (Phase 4)Study completedNCT00654589
What this trial is testing

Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload

Who this might be right for
Iron Overload
Novartis Pharmaceuticals 75
Testing effectiveness (Phase 2)Looking for participantsNCT07256210
What this trial is testing

Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Very early researchLooking for participantsNCT07126782
What this trial is testing

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)AML
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02420860
What this trial is testing

Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma
M.D. Anderson Cancer Center 113
Large-scale testing (Phase 3)Study completedNCT02634294
What this trial is testing

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematological NeoplasmsRecurrence
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT03019809
What this trial is testing

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Who this might be right for
Wiskott-Aldrich SyndromeHematopoietic Stem Cell TransplantationGraft Failure
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Early research (Phase 1)WithdrawnNCT05589844
What this trial is testing

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegaloviral InfectionHematopoietic and Lymphoid System Neoplasm
Roswell Park Cancer Institute
Next Page